Business Wire

CORSEARCH

23.5.2024 14:44:27 CEST | Business Wire | Press release

Share
Number of Active Global Trademarks to Surpass the 100 Million Mark in Just Three Years, Finds Corsearch

Corsearch, the leading provider of brand protection and trademark solutions, has today shared research forecasting that the number of active global trademarks will surpass the 100 million mark by 2026, in just two years.

Data from the Corsearch TrademarkNow platform shows that there were 83,613,385 active trademarks at the end of 2023, predicted to rise to 88,072,867 by the end of this year. Corsearch calculations forecast that by 2026, this figure will reach 100,720,928 – an increase of over 150% from the 2016 figures from a decade prior.

This growth in active trademark volumes demonstrates the increasing number of intellectual properties being developed and used by organizations across the world, in addition to a growing focus on the importance of protecting your intangible assets.

Examining 2024 filing figures, Corsearch can reveal that the country with the most active companies filing trademarks is China, followed swiftly by the USA and Brazil. The UK ranks 8th globally and, of the EU, only France features in the top ten most active filing countries.

Trademark volume rankings by originating country, 2023

1.

China

2.

USA

3.

Brazil

4.

India

5.

Turkey

6.

Mexico

7.

Japan

8.

United Kingdom

9.

Russia

10.

France

In order to support in-house counsel and expert IP advisors through this period of significant growth, Corsearch has also today announced its next-generation TrademarkNow platform. Lightning-fast AI and insights from 1,000+ sources ensure comprehensive trademark searching and monitoring – upgrades include:

  • 75% faster turnaround time for notices than other industry solutions. Automated and Expert Watch solutions offer options between AI technology to deliver efficient monitoring of trademarks in the face of expanding trademark portfolios without sacrificing accuracy, or bespoke strategies and focused insights for more complex, high-value matters
  • 40% improvement in IP legal team speeds of delivery for brand name clearance, with Corsearch LogoCheck and Name Generator tools allowing better searching of existing brand identities in combination with AI suggestions of candidate names
  • Industrial Designs can be searched faster and more accurately through new similarity algorithms and the Corsearch AI image recognition engine
  • ExaMatch search modifiers and NameCheck reporting allow for more targeted search queries and customizable reports better fit for individual needs

Viji Krishnan, President of Trademark Solutions, Corsearch, commented:

“Over the past years, the world has been waking up to the importance of trademarking intangible assets and intellectual property, and the risks of not doing so. It’s no surprise that we are only a few years away from seeing over 100 million trademarks active across the globe. It’s an optimistic sign of the intense innovation fuelling global organizations and empowering global business.

“But as with most things: the higher the volume of actively registered trademarks, the greater the potential complexity for IP professionals. We’re delighted to be launching our next-generation TrademarkNow platform to help experts in our sector cut through the noise. New AI tools will operate at the sheer scale needed to manage the size of modern trademark portfolios, effective dashboards which help prioritize work and the combined human expertise of our analysts who average over 15 years’ experience, ensures that brands uphold trademark distinctiveness.”

Notes to Editors

Methodology

Corsearch calculations are based on the data sourced from the TrademarkNow™ global trademark platform spanning all global trademark offices and registries. Where applicable, the effects of COVID on trademark filing have been accounted for.

About Corsearch:

Corsearch’s leading Trademark and Brand & Content Protection Solutions are revolutionizing how companies create, monitor, and protect their brands. Over 5,000 businesses worldwide partner with Corsearch to safeguard consumers and their trust in brands — preventing confusion, misrepresentation, and fraud using the hybrid intelligence of advanced AI precision and expert decision of human analysts.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240521172877/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye